News & Events

Lymphedema & Lymphatic Disease Matters, November 2021

No images? Click here to view this email in your browser.

November 2021

From William Repicci, President & CEO

We conclude another eventful month on #GivingTuesday, a global day of giving set aside to support the causes we care about. If you care about fighting lymphatic diseases such as lymphedema, lipedema, and lymphatic anomalies, take a moment to make a donation, of any size, to LE&RN, either through a Facebook fundraiser (LE&RN's is here) or at CureLymph.orgYour gift today will be matched, dollar-for-dollar, because of a generous match pledge made by LE&RN Supporters Ian Laming and Stephanie Free. 

November 12-13, LE&RN hosted the State-of-the-Art Lymphatic Medicine Virtual Summit. Over 500 participants came together from dozens of countries around the world. Our thanks to all those who made this a hugely successful event.

My thanks also to all the organizers of the November 5-6 Boston Lymphatic Clinical Symposium, where I was honored to introduce keynote speaker Dr. Zorina Galis (NIH/NHLBI) and serve as a moderator on the Centers of Excellence session. Dr. Dhruv Singhal of the Boston Lymphatic Center began the Symposium with a tribute to LE&RN Director, Pamela Ross, who passed away from COVID in 2020. And finally, my gratitude to Dr. Christine Moffitt who invited me to deliver a talk entitled The Advent of Lymphedema's Modern Era at the International Lymphedema Framework conference November 18-20 held both virtually and in-person in Copenhagen.

The Gordon Research Conference: Lymphatics will be held from February 27 to March 4 in Italy. LE&RN is offering Travel Awards for young investigators. We are also now accepting nominations for the Lifetime Achievement Award as well as the Career Achievement Award. See the newsletter for more information, including applications and deadlines.

As President & CEO of LE&RN, I thank you for your ongoing support, which makes our progress possible. I am pleased to present you with the November edition of Lymphedema & Lymphatic Disease Matters.

 

#GivingTuesday

Today is Giving Tuesday, a day set aside for supporting the causes we all care about. LE&RN Spokesperson Kathy Bates kicked off the day, asking our community to come together for the day so that our fight against lymphatic diseases such as lymphedema, lipedema, and lymphatic anomalies can continue through 2022 and beyond. Our community did not disappoint. Supporters set up dozens of Facebook fundraisers, others contributed to LE&RN's #GivingTuesday fundraiser on Facebook, and still others made donations to this year's Annual Appeal at CureLymph.org. We sincerely thank all those who participated and ask those who have not yet donated to give any amount right now. Thanks to a generous match pledge, all donations go twice as far.
Give on Facebook
Give at CureLymph.org
 

Centers of Excellence

Letters of Intent for the 2022 Centers of Excellence (COE) are now being accepted through January 14, 2022. Currently, there are 35 COEs.
Applications/letters can only be submitted online. Inquiries can be directed to COE@LymphaticNetwork.org.

Learn more about COEs
 

"State-of-the-Art Lymphatic Medicine" Virtual Summit draws global audience

Centers of Excellence Lymphatic Summit 2021: The Continuum from Evolving Research to State-of-the-Art Lymphatic Management was held online, November 12-13. Dr. Stanley G. Rockson, the Allan and Tina Neill Professor of Lymphatic Research and Medicine at Stanford University and Founding Chair of LE&RN's Scientific & Medical Advisory Council; William Repicci, President & CEO of LE&RN; and Kathy Bates, Academy Award-winning actress and LE&RN's National Spokesperson, provided opening remarks.

The Summit is now available as a replay online with 9 AMA PRA Category 1 Credits™ still available to physicians.

Register and view for CME credits
 

"Pathomechanisms of Lipo-lymphedema" with Steven M. Dean, DO, FSVM, RPVI

Please join us for this free online Symposium with Steven M. Dean, DO, FSVM, RPVI, on Tuesday, December 7, 2021, at 1pm ET. Registration links will be provided shortly.